AEs leading to trial product discontinuation occurred in 51/603 (8.5%) participants in the CagriSema 2.4 mg/2.4 mg group, 40/605 (6.6%) participants in the semaglutide 2.4 mg group, 7/152 (4.6%) participants in the cagrilintide 2.4 mg group, 42/594 (7.1%) participants in the CagriSema 1 mg/1 mg group, 26/608 (4.3%) participants in the semaglutide 1 mg group, and 2/149 (1.3%) participants in the placebo group
Its especially beneficial for individuals with absorption issues, such as those with gastrointestinal disorders or after certain surgeries
Chen XF, Li Z, Ping P, Dai JC, Zhang FB, Shang XJ
With a personalized, science-backed approach, we enhance your natural beauty and well-being through advanced treatments, including Vitamin B12 injections in Austin
Serving patients from McKinney, Allen, Frisco, Plano, and North Dallas
Collagen boost to support skin firmness & reduction of wrinkles